- Diagnosis and Treatment of GastroEsophageal Reflux Disease at the Primary Health Care Clinics in Korea
-
Kim YS, Kang DH, Park HC, Oh TH, Kim YS
- KMID: 2547288
- Korean J Gastroenterol.
- 2023 Oct;82(4):180-189.
- doi: 10.4166/kjg.2023.032
Background/Aims: The prevalence of GERD and treatment costs are continuously rising in Korea, and the importance of primary health care clinics where the most treatment of actual patients is conducted... -
- CITED
-
- Close
- SHARE
-
- Close
- Intra-sinus rigid fixation of a resorbable barrier membrane to repair a large perforation of the sinus membrane: a technical note
-
Joung WJ, Yun SH, Kim Y, Cho YS, Lee WW, Seo JW, Tallarico M, Hwang KG, Park CJ
- KMID: 2547575
- J Korean Assoc Oral Maxillofac Surg.
- 2023 Oct;49(5):297-303.
- doi: 10.5125/jkaoms.2023.49.5.297
A resorbable barrier membrane is commonly used for the repair of perforated sinus membranes during sinus lifting surgeries. However, repairing largescale perforations poses challenges for clinicians as the protection and... -
- CITED
-
- Close
- SHARE
-
- Close
- Size-reduced fexuprazan 20 mg demonstrated the optimal bioavailability and bioequivalence with the reference formulation
-
Yang AY, Yoo H, Shin W, Lee YS, Lee H, Kim SE, Kim A
- KMID: 2552405
- Transl Clin Pharmacol.
- 2023 Mar;31(1):40-48.
- doi: 10.12793/tcp.2023.31.e3
Fexuprazan (DWP14012), a potassium-competitive acid blocker, is a medical formulation prescribed to inhibit the secretion of gastric acid. The present study encompasses a comparative evaluation of pharmacokinetic (PK) analysis between... -
- CITED
-
- Close
- SHARE
-
- Close
- Promising Therapeutic Effects of Embryonic Stem Cells-Origin Mesenchymal Stem Cells in Experimental Pulmonary Fibrosis Models: Immunomodulatory and Anti-Apoptotic Mechanisms
-
Lee H, Jeong OY, Park HJ, Lee SL, Bok Ey, Kim M, Suh YS, Cheon YH, Kim HO, Kim S, Chun SH, Park JM, Lee YJ, Lee SI
- KMID: 2549965
- Immune Netw.
- 2023 Dec;23(6):e45.
- doi: 10.4110/in.2023.23.e45
Interstitial lung disease (ILD) involves persistent inflammation and fibrosis, leading to respiratory failure and even death. Adult tissue-derived mesenchymal stem cells (MSCs) show potential in ILD therapeutics but obtaining an... -
- CITED
-
- Close
- SHARE
-
- Close
